对于非小细胞肺癌的新兴外科手术期治疗模式:叙述性审查

Petros Christopoulos1

  • 1Department of Oncology, Thoraxklinik and National Center for Tumor Diseases (NCT) at Heidelberg University Hospital, Heidelberg, Germany; Translational Lung Research Center Heidelberg, Member of the German Center for Lung Research (DZL), Heidelberg, Germany.

Chinese clinical oncology
|February 19, 2024
PubMed
概括

术后免疫疗法和向药物正在彻底改变可切除非小细胞肺癌 (NSCLC) 治疗. 提前分子分析对于选择患者接受这些先进疗法至关重要,从而改善治疗结果.